Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Pol

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Cell Research|March 30, 2018
Anti-CTLA-4 immunotherapy: uncoupling toxicity and efficacyJonathan Pol, Guido Kroemer
Gut|April 17, 2024
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient managementLuca Fabris, Jonathan Pol
Medecine Sciences : M/S|July 10, 2024
[The immunocytokine FAP-IL2v : a potent co-therapy for preventing resistance to trastuzumab in HER2<sup>+</sup> breast cancer]Eléonore Parisel, Laura Prudhomme, Jonathan Pol
Oncoimmunology|March 5, 2016
First oncolytic virus approved for melanoma immunotherapyJonathan Pol, Guido Kroemer, Lorenzo Galluzzi
Cell Cycle (Georgetown, Tex.)|September 3, 2016
Fasting improves anticancer immunosurveillance via autophagy induction in malignant cellsFederico Pietrocola, Jonathan Pol, Guido Kroemer
Oncoimmunology|March 15, 2021
Tumor-intrinsic determinants of immunogenic cell death modalitiesSamuel T Workenhe, Jonathan Pol, Guido Kroemer
Medecine Sciences : M/S|July 3, 2020
[Fasting reduces inflammation associated with chronic inflammatory diseases without affecting the immune response to acute infections]Leslie Adda, Sara Abou Melhem, Jonathan Pol
Oncoimmunology|January 24, 2022
Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseasesJonathan Pol, Juliette Paillet, Céleste Plantureux, et al.
Medecine Sciences : M/S|September 7, 2021
[Interaction between HMGB1/Tetranectine as a possible therapeutic target in sepsis?]Yasmine Adimi, Mathieu Esposito, Rayan Braik, et al.
Medecine Sciences : M/S|March 5, 2013
[Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses]Jonathan Pol, Fabrice Le Bœuf, Jean-Simon Diallo
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Cell Research|March 30, 2018
Anti-CTLA-4 immunotherapy: uncoupling toxicity and efficacyJonathan Pol, Guido Kroemer
Gut|April 17, 2024
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient managementLuca Fabris, Jonathan Pol
Medecine Sciences : M/S|July 10, 2024
[The immunocytokine FAP-IL2v : a potent co-therapy for preventing resistance to trastuzumab in HER2<sup>+</sup> breast cancer]Eléonore Parisel, Laura Prudhomme, Jonathan Pol
Oncoimmunology|March 5, 2016
First oncolytic virus approved for melanoma immunotherapyJonathan Pol, Guido Kroemer, Lorenzo Galluzzi
Cell Cycle (Georgetown, Tex.)|September 3, 2016
Fasting improves anticancer immunosurveillance via autophagy induction in malignant cellsFederico Pietrocola, Jonathan Pol, Guido Kroemer
Oncoimmunology|March 15, 2021
Tumor-intrinsic determinants of immunogenic cell death modalitiesSamuel T Workenhe, Jonathan Pol, Guido Kroemer
Medecine Sciences : M/S|July 3, 2020
[Fasting reduces inflammation associated with chronic inflammatory diseases without affecting the immune response to acute infections]Leslie Adda, Sara Abou Melhem, Jonathan Pol
Oncoimmunology|January 24, 2022
Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseasesJonathan Pol, Juliette Paillet, Céleste Plantureux, et al.
Medecine Sciences : M/S|September 7, 2021
[Interaction between HMGB1/Tetranectine as a possible therapeutic target in sepsis?]Yasmine Adimi, Mathieu Esposito, Rayan Braik, et al.
Medecine Sciences : M/S|March 5, 2013
[Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses]Jonathan Pol, Fabrice Le Bœuf, Jean-Simon Diallo
Pageof 7